Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.21+0.05 (+1.20%)
Close on Nov 20, 2026Market cap $1.51BP/E –Yield –
Precigen free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Precigen's free cash flow for the twelve months ending Jun 30, 2026 was -$115.22M. For fiscal 2025 it was -$89.83M. The highest annual figure on record is $22.92M in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$89.83M | – |
| FY2024 | Dec 31, 2024 | -$76.76M | – |
| FY2023 | Dec 31, 2023 | -$68.47M | – |
| FY2022 | Dec 31, 2022 | -$69.97M | – |
| FY2021 | Dec 31, 2021 | -$63.02M | – |
| FY2020 | Dec 31, 2020 | -$84.55M | – |
| FY2019 | Dec 31, 2019 | -$173.81M | – |
| FY2018 | Dec 31, 2018 | -$165.83M | – |
| FY2017 | Dec 31, 2017 | -$150.39M | – |
| FY2016 | Dec 31, 2016 | -$80.62M | -451.7% |
| FY2015 | Dec 31, 2015 | $22.92M | – |
| FY2014 | Dec 31, 2014 | -$26.23M | – |
| FY2013 | Dec 31, 2013 | -$55.21M | – |
| FY2012 | Dec 31, 2012 | -$69.02M | – |
| FY2011 | Dec 31, 2011 | -$94.76M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$18.20M | – |
| Q1 FY2026 | Mar 31, 2026 | -$44.09M | – |
| Q4 FY2025 | Dec 31, 2025 | -$23.48M | – |
| Q3 FY2025 | Sep 30, 2025 | -$29.46M | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.94M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.95M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.27M | – |
| Q3 FY2024 | Sep 30, 2024 | -$23.62M | – |
| Q2 FY2024 | Jun 30, 2024 | -$25.43M | – |
| Q1 FY2024 | Mar 31, 2024 | -$18.44M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.81M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.24M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$18.54M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$25.39M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.77M | – |
| Q1 FY2022 | Mar 31, 2022 | -$20.36M | – |
| Q4 FY2021 | Dec 31, 2021 | -$17.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$19.29M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.97M | – |
| Q1 FY2021 | Mar 31, 2021 | -$17.40M | – |
| Q4 FY2020 | Dec 31, 2020 | -$17.94M | – |
| Q3 FY2020 | Sep 30, 2020 | -$20.03M | – |
| Q2 FY2020 | Jun 30, 2020 | -$15.69M | – |
| Q1 FY2020 | Mar 31, 2020 | -$30.90M | – |
| Q4 FY2019 | Dec 31, 2019 | -$36.83M | – |
| Q3 FY2019 | Sep 30, 2019 | -$34.92M | – |
| Q2 FY2019 | Jun 30, 2019 | -$47.30M | – |
| Q1 FY2019 | Mar 31, 2019 | -$54.76M | – |
| Q4 FY2018 | Dec 31, 2018 | -$48.60M | – |
| Q3 FY2018 | Sep 30, 2018 | -$37.59M | – |
| Q2 FY2018 | Jun 30, 2018 | -$38.99M | – |
| Q1 FY2018 | Mar 31, 2018 | -$40.66M | – |
| Q4 FY2017 | Dec 31, 2017 | -$47.87M | – |
| Q3 FY2017 | Sep 30, 2017 | -$36.42M | – |
| Q2 FY2017 | Jun 30, 2017 | -$35.06M | – |
| Q1 FY2017 | Mar 31, 2017 | -$31.03M | – |
| Q4 FY2016 | Dec 31, 2016 | -$28.64M | – |
| Q3 FY2016 | Sep 30, 2016 | -$25.89M | – |
See a number that looks wrong?